Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(29 sites)
China
The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui
Peking Union Medical College Hospital, Beijing, Beijing Municipality
Xuanwu Hospital Capital Medical University, Beijing, Beijing Municipality
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing Municipality
Peking University Third Hospital, Beijing, Beijing Municipality
The Southwest Hospital of Amu, Chongqing, Chongqing Municipality
The First Affiliated Hospital of Fujan Medical University, Fuzhou, Fujian
Gansu Provincial Cancer Hospital, Lanzhou, Gansu
Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong
Dermatology Hospital of Southern Medical University (Guangdong Provincial Dermatology Hospital / Guangdong Center for the Prevention and Control of Sexually Transmitted Diseases and Leprosy, Guangzhou, Guangdong
Guangxi Medical University Cancer Hospital （ Guangxi Cancer InstituteGuangxi Cancer Hospital & Medical University Oncology School & Cancer Center）, Nanning, Guangxi